WASHINGTON: The US Meals and Drug Administration (FDA) on Wednesday (Aug 27) accredited up to date COVID-19 vaccines for everybody aged 65 and over however narrowed entry for youthful individuals to these with well being dangers, a shift from earlier years when most Individuals had been eligible.
The three accredited pictures are made by Pfizer and German accomplice BioNTech, Moderna, and Novavax with Sanofi.
“As we speak’s determination doesn’t have an effect on entry to those vaccines. These vaccines stay out there to those that select them in session with their healthcare supplier,” a US Division of Well being and Human Providers (HHS) spokesperson mentioned.
CHILDREN’S ACCESS CURTAILED
Pfizer mentioned the emergency use authorisation for its COVID vaccine for kids underneath 5 was rescinded, probably limiting entry for paediatric teams.
Moderna mentioned its up to date Spikevax shot was accredited for individuals aged six months and older with no less than one underlying situation, and could be out there within the coming days.
Pfizer and BioNTech’s up to date Comirnaty was cleared for individuals aged 5 to 64 with high-risk circumstances. Novavax’s vaccine was accredited underneath the identical standards for these aged 12 to 64.
All three vaccines stay out there to individuals 65 and older with out restrictions.
